CD14 modulates inflammation-driven insulin resistance

Diabetes

Volumn 60, Issue 8, 2011, Pages 2179-2186

  Fernández Real, José Manuel ^a   Del Pulgar, Sofia Pérez ^a,b,c   Luche, Elodie ^d,e   Moreno Navarrete, José Maria ^a   Waget, Aurelie ^d,e   Serino, Matteo ^d,e   Sorianello, Eleonora ^c   Sánchez Pla, Alex ^c,f   Pontaque, Francesc Carmona ^c   Vendrell, Joan ^b   Chacón, Matilde R ^b   Ricart, Wifredo ^a   Burcelin, Remy ^d,e   Zorzano, Antonio ^c  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSERM   (France)

^e UNIVERSITÉ DE TOULOUSE   (France)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GLUCOSE; INSULIN; MESSENGER RNA;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE INTOLERANCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD14; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; DIETARY FATS; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; MICE, OBESE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052834727     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1210     Document Type: Article

References (30)

1. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998;41:1241-1248
2. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278-301 (Pubitemid 36724371)
3. Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1780-1784 (Pubitemid 36623404)
4. Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2008;19:10-16
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808 (Pubitemid 38063703)
6. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830 (Pubitemid 38063705)
7. Tsou CL, Peters W, Si Y, et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007;117:902-909 (Pubitemid 46556746)
8. Saberi M, Woods NB, de Luca C, et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009;10:419-429
9. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433
10. Pugin J, Heumann ID, Tomasz A, et al. CD14 is a pattern recognition receptor. Immunity 1994;1:509-516
11. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13:437-457
12. Jiang Q, Akashi S, Miyake K, Petty HR. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000;165:3541-3544 (Pubitemid 32057253)
13. Pan Z, Zhou L, Hetherington CJ, Zhang DE. Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes. J Biol Chem 2000;275:36430-36435
14. Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 1995;181:857-866
15. Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 1999;163:33-38 (Pubitemid 29481300)
16. Daniel JA, Elsasser TH, Morrison CD, et al. Leptin, tumor necrosis factoralpha (TNF), and CD14 in ovine adipose tissue and changes in circulating TNF in lean and fat sheep. J Anim Sci 2003;81:2590-2599 (Pubitemid 38571664)
17. Johnson GB, Riggs BL, Platt JL. A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J 2004;18:1282-1284
18. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-1772 (Pubitemid 47025442)
19. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009;150:2109-2117
20. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116: 3015-3025 (Pubitemid 44684486)
21. Poggi M, Bastelica D, Gual P, et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007;50:1267-1276 (Pubitemid 46701560) (Pubitemid 46701560)
22. Pérez-Pérez R, Ortega-Delgado FJ, García-Santos E, et al. Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J Proteome Res 2009;8: 1682-1693
23. Thompson PA, Tobias PS, Viriyakosol S, Kirkland TN, Kitchens RL. Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem 2003;278:28367-28371 (Pubitemid 36935736) (Pubitemid 36935736)
24. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990;86:696-702 (Pubitemid 20327356) (Pubitemid 20327356)
25. Michel OJ, Kips J, Duchateau J, et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996;154:1641-1646 (Pubitemid 26424928) (Pubitemid 26424928)
26. Amar J, Burcelin R, Ruidavets JB, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008;87:1219-1223 (Pubitemid 351679761) (Pubitemid 351679761)
27. Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ. Endotoxin and bacteria in portal blood. Gastroenterology 1977;72:1268-1270 (Pubitemid 8116697) (Pubitemid 8116697)
28. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-1481
29. Manco M, Fernandez-Real JM, Vecchio FM, et al. The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgeryinduced amelioration of NASH in obesity. Obes Surg 2010;20:1682-1689
30. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-192 (Pubitemid 34764822) (Pubitemid 34764822)